(Q44132580)

30 November 2017

Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma (English)

1 reference

30 November 2017

0 references

4

Hidetaka Katabuchi

1 reference

30 November 2017

5

Hitoshi Okamura

1 reference

30 November 2017

Kentaro Nakayama

1

1 reference

30 November 2017

Atsuko Kanzaki

2

1 reference

30 November 2017

Kohkichi Hata

3

1 reference

30 November 2017

Kohji Miyazaki

6

1 reference

30 November 2017

Manabu Fukumoto

7

1 reference

30 November 2017

Yuji Takebayashi

8

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

30 November 2017

1 reference

30 November 2017

176

1 reference

30 November 2017

215-223

1 reference

30 November 2017

2

1 reference

Induction of angiogenesis during the transition from hyperplasia to neoplasia

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Antiangiogenic therapy of transgenic mice impairs de novo tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Oncogenic alterations of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

The hypoxic response: huffing and HIFing

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Prognostic value of vascular endothelial growth factor expression in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Prognostic value of vascular endothelial growth factor in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Differences in the angiogenesis of benign and malignant ovarian tumors, demonstrated by analyses of color Doppler ultrasound, immunohistochemistry, and microvessel density

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Angiogenesis in early-invasive and low-malignant-potential epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Expression of thymidine phosphorylase in epithelial ovarian cancer: correlation with angiogenesis, apoptosis, and ultrasound-derived peak systolic velocity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

VEGF, VEGFR-1, VEGFR-2, microvessel density and endothelial cell proliferation in tumours of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Different features of angiogenesis between ovarian and breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Potential role of the inactivated X chromosome in ovarian epithelial tumor development.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

Analysis of gene amplification and overexpression in human esophageal-carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900762-5

7 January 2021

10.1016/S0304-3835(01)00762-5

Identifiers

DOI

1 reference

30 November 2017

1 reference